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Background: PAP is a ribosome-inactivating protein that depurinates RNA and inhibits protein synthesis.
Results: Turnip mosaic VPg inhibits enzymatic activity of PAP in wheat germ extract.
Conclusion: VPg may play a role in overcoming viral resistance by suppressing the plant defense mechanism.
Significance: Depurination inhibition by VPg suggests a novel viral strategy to evade host cell defense and possible anti-
cytotoxic activity against RIPs.
Pokeweed antiviral protein (PAP) from Phytolacca ameri-
cana is a ribosome-inactivating protein (RIP) and an RNA
N-glycosidase that removes specific purine residues from the
sarcin/ricin loop of large rRNA, arresting protein synthesis at
the translocation step. PAP is also a cap-binding protein and is a
potent antiviral agent against many plant, animal, and human
viruses. To elucidate the mechanism of RNA depurination, and
to understand how PAP recognizes and targets various RNAs,
the interactions between PAP and turnip mosaic virus genome-
linked protein (VPg) were investigated. VPg can function as a
cap analog in cap-independent translation and potentially tar-
get PAP to uncapped IRES-containing RNA. In this work, fluo-
rescence spectroscopy andHPLC techniqueswere used to quan-
titatively describe PAP depurination activity and PAP-VPg
interactions. PAP binds to VPg with high affinity (29.5 nM); the
reaction is enthalpically driven and entropically favored. Fur-
ther, VPg is a potent inhibitor of PAP depurination of RNA in
wheat germ lysate and competes with structured RNA derived
from tobacco etch virus for PAP binding. VPg may confer an
evolutionary advantage by suppressing one of the plant defense
mechanisms and also suggests the possible use of this protein
against the cytotoxic activity of ribosome-inactivating proteins.
Pokeweed antiviral protein (PAP)2 is a ribosome-inactivating
protein (RIP) that is isolated from the extracts of pokeweed
plant leaves (Phytolacca americana) (1). It is known to reduce
infectivity of tobaccomosaic virus (2) by inhibiting protein syn-
thesis (3). PAP, ricin, abrin, and otherRIPs inactivate ribosomes
and inhibit cell-free protein synthesis by means of arresting the
function of elongation factor EF-2 (4, 5) in the translocation
step (6–8). The N-glycosidase domain of RIPs recognizes a
specific and highly conserved region, the sarcin/ricin (S/R) loop
(9), within the large 28S rRNA, and cleaves a distinct A4324
residue on the RNA (for rat liver ribosome). This depurination
arrests cellular protein synthesis and leads to the activation of
apoptotic pathways (10). Ribosomal proteins and structural dif-
ferences between RIPs themselves account for the diversified
activity of RIPs and ribosome substrate specificity (11, 12).
The mode of action for the antiviral activity of RIPs is poorly
understood, but there is evidence that this activity does not
depend solely on ribosomal inactivation. PAP isoforms cause a
concentration-dependent depurination of HIV-1 (13), tobacco
mosaic virus (14), poliovirus (15), HSV (16), influenza (17), and
brome mosaic virus RNAs (18).
PAP inhibits the in vitro translation of brome mosaic virus
and potato virus X RNAs without ribosomal depurination (19)
by binding to the cap structure and depurinating the RNA. This
may be the primary mechanism for PAP antiviral activity (20);
however, it does not clarify the inhibitory effects of PAP on the
replication of uncapped viruses, such as influenza (17) and
poliovirus (15). Further, PAP does not depurinate every capped
RNA, and it can inhibit translation of uncapped viral RNAs in
vitro without causing detectable depurination at multiple sites
(21). Thus, recognition of the cap structure alone is not suffi-
cient for depurination of RNA (21).
In the presence of wheat germ lysate, PAP depurinates
uncapped barley yellow dwarf virus transcripts containing a
functional WT 3-translation enhancer sequence but does not
depurinate messages containing a non-functional mutant
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3-translation enhancer sequence (22). This suggests that PAP
binding to eIF4G/iso4G provides a mechanism for PAP to
access both uncapped and capped viral RNAs for depurination.
PAP binds to the eIFiso4G, and the presence of cap analog
increases these protein-protein interactions (23), suggesting
that PAP binds to the 5-m7G cap of mRNA.
To understand how PAP recognizes and selectively targets
RNAs, interactions between PAP and TuMV genome-linked
protein (VPg) were investigated. VPg is a 22-kDa potyviral pro-
tein, covalently attached via a Tyr residue (24) to the genomes
of one-quarter of the plant positive strand RNA viruses, includ-
ing the Potyviridae genus. VPg plays a pivotal role in the viral
infection cycle, replication, and cell-to-cell movement and also
has been implicated in overcoming viral resistance in plants
(25). Interactions between VPg of TuMV and the eIFiso4E/
iso4F of Arabidopsis thaliana (26, 27) suggest that VPg is
important in the initiation of protein synthesis (28). Interac-
tions between VPg and plant eIFiso4E and effects of eIFiso4G
on these interactions have been characterized (29–31). VPg
stimulates the in vitro translation of uncapped IRES-containing
RNA by targeting eIF4F to the IRES and inhibits capped RNA
translation in wheat germ extracts (32).
In this study, fluorescence spectroscopy and HPLC tech-
niques were used to quantitatively describe PAP-VPg interac-
tions. PAP interacts strongly with VPg in a mixed type compe-
tition for m7GTP cap analog. PAP binds to and depurinates an
S/R oligonucleotide, capped and uncapped tobacco etch virus
(TEV), and luciferase mRNA, supporting previous conclusions
that the cap structure is not the only determinant within the
RNA for depurination by PAP. PAP binds to VPg at a different
site from the eIFiso4F/eIF4F binding site. The effect of VPg on
the depurination of selected RNA molecules, including struc-
tured RNA derived from TEV (33–35), showed that VPg
decreases depurination of RNAs and competes with IRES con-
taining TEV RNA for PAP binding. These findings correlate
with the inhibition of PAP enzymatic activity by VPg in wheat
germ lysate. Depurination inhibition by VPg may confer an
advantage for viral replication, and may be a novel mechanism
to overcome plant defenses.
EXPERIMENTAL PROCEDURES
Materials—All chemicals used (unless otherwise noted)were
of molecular biology grade. Tris-HCl, HEPES, KCl, dithiothre-
itol (DTT), phenylmethylsulfonyl fluoride (PMSF), aprotinin,
soybean trypsin inhibitor, diethylpyrocarbonate, EDTA, and
the m7GTP analog were purchased from Sigma. Polyvinylpyr-
rolidonewas purchased fromSpectrum. PromegaRiboMAXTM
large scale RNAproduction systemT7 and SP6were used for in
vitro RNA and S/R oligonucleotide synthesis. Peptone, yeast
extract, and NaCl were purchased from Fisher. The SalI and
NcoI restriction endonucleaseswere purchased fromNewEng-
land Biolabs. HiTrap FF chromatography columns (Mono Q
and SP) were from GE Healthcare. Plasmid isolation kits and
nickel-nitrilotriacetic acid Superflow column were purchased
from Qiagen.
Purification of Pokeweed Antiviral Protein—PAP used for
these experiments was isolated from the spring leaves of the
pokeweed plant (Phytolacca americana) as described previ-
ously (23). PAP was purified using the A¨KTApurifier system
from GE Healthcare, equipped with pump P-900, monitor
UV-900, monitor UPC-900, valve INV-907, and mixer M-925.
The protein fractions were analyzed by 12% SDS-PAGE for
purity, and the protein concentration was determined using a
Pierce Coomassie assay with BSA as the standard.
Expression and Purification of Wild Type (WT) VPg-His6,
VPg-71-His6, and VPg-220-His6—Purification of TuMV VPg
was described previously (29). VPg was purified with the
A¨KTApurifier system. Purification of VPg-71-His6 and VPg-
220-His6 truncated proteins followed an analogous procedure.
The purity of all of the proteins was confirmed by 12% SDS-
PAGE, and the protein concentrationwas determined using the
PierceCoomassie assaywith BSA as the standard. Prior to spec-
troscopic measurements, all samples were dialyzed against
buffer E (20 mM HEPES-KOH, pH 7.6, 100 mM KCl, 1.0 mM
MgCl2, 1.0mMDTT, 1.0mMEDTA), passed through a 0.22-m
Millipore filter, and concentrated with a Centricon 10 concen-
trator (Amicon Co.) as necessary.
Expression and Purification of Eukaryotic Translation Initia-
tion Factors (eIFs)—The cap binding and scaffolding initiation
factors (eIFiso4G and eIFiso4E) were expressed in Escherichia
coli containing the constructed pET-3d vector in BL21(DE3)-
pLysS cells, as described previously (31). All samples were ana-
lyzed by 12%SDS-PAGEand showedhomogeneously pure pro-
teins. All protein purification steps were carried out in a cold
room at 4 °C.
InVitro Synthesis of TEVRNA, S/ROligonucleotide RNA, and
Luciferase mRNA—TEVDNA constructs were kindly provided
by Daniel R. Gallie (University of California, Riverside, CA).
The full-length TEV construct was cloned as described previ-
ously (33). The TEV1–143 leader sequence was positioned next
to the SP6 promoter of the PTL7SN.3 GUS vector. DNA was
linearizedwithNcoI. The linearizedDNAwas treatedwith pro-
teinase K (100g/ml) and 0.5% SDS in 50mMTris-HCl, pH 7.5,
5 mM CaCl2 for 30 min at 37 °C. DNA was further purified by
extraction with phenol/chloroform/isoamyl alcohol (25:24:1)
at pH 8.0 followed by ethanol precipitation. Purity of the
resulted DNA was checked on a 1% agarose gel, and the con-
centration was quantified spectrophotometrically and brought
to 0.5 mg/ml. In vitro transcription of the TEV DNA used Pro-
mega RiboMAXTM large scale RNAproduction system SP6 fol-
lowing the manufacturer’s protocol. Cap analog, m7G(5)ppp-
(5)G, was incorporated into the TEV transcript during the
RiboMAXTM transcription reaction. The ratio of cap analog/
GTPwas 5:1 to increase the efficiency of the transcription reac-
tion. Capped and uncapped transcripts were analyzed on 20%
denaturing polyacrylamide, 8 M urea gels, and the synthesized
products were visualized by ethidium bromide staining. Under
the conditions of transcription, more than 75% of RNA tran-
scripts were capped, as determined by the fluorescence inten-
sity of ethidium bromide. Capped RNA transcripts were sliced
from the gels, redissolved in a buffer solution, precipitated with
ethanol, and repurified. The concentration of TEV RNA was
determined bymeasuring the optical density at 260 nm, and the
purity of the synthesized RNAwas confirmed bymeasuring the
absorbance ratio A260/A280 in diethylpyrocarbonate-treated
water. The S/R oligonucleotide dsDNA template (5-GGATC-
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CTAATACGACTCACTATAGGGTGAACTTAGTACGAG-
AGGAACAGTTCA-3; 53 nucleotides) was purchased from
Gene LinkTM with the sequence corresponding to the univer-
sally conserved S/R loop of the large rRNA. The linear DNA
template was treated with proteinase K and purified by phenol/
chloroform extraction as for TEVDNA. In vitro synthesis of the
S/R oligonucleotide RNA used Promega RiboMAXTM large
scale RNA production system T7 following the manufacturer’s
protocol. Cap analog, m7G(5)ppp(5)G, was incorporated into
the RNA transcripts during the RiboMAXTM transcription
reaction. The plasmid pLUC0 (36) containing the luciferase
gene was linearized with DraI and used as template for synthe-
sis of the in vitro transcript. pLUC0 contains a linker sequence
(GGCCTAAGCTTGTCGACC) between the T7 promoter and
the ATG of luciferase. Following the TAA stop codon of lucif-
erase is a poly(A) tail of 50A nucleotides immediately upstream
of the DraI site. Both capped and uncapped luciferase RNAs
were synthesized as run-off transcripts of aT7polymerase reac-
tion (Promega), as described previously (20).
Fluorescence Assay for Adenine Released by PAP—Experi-
ments were performed by incubating RNA (10 nmol/ml) in
Depurination Buffer (20 mM Tris-HCl, pH 7.5, 100 mMNH4Cl,
7mMmagnesium acetate, and 1mMDTT) for 15min at 37 °C in
the absence and presence of PAP and VPg in 100-l reaction
volumes. At the end of the incubations, 1 volume of cold etha-
nol was added, and after 10 min at80 °C, the ethanol-soluble
fractions were recovered by centrifugation for 15 min at 14,000
rpm. Free adenine present in the ethanol-soluble fractions was
converted into its etheno derivative (37–39); 150 l portions of
the ethanol-soluble fractions were each diluted to 1 ml with
diethylpyrocarbonate-treated water, and 0.4 ml of a mixture of
0.14 M chloroacetaldehyde and 0.1 M sodium acetate buffer, pH
5.1, was added to each. The samples were heated in awater bath
at 80 °C for 40min, extracted four timeswith 1 volumeofwater-
saturated diethyl ether, and passed through 0.45-m pore size
filters. Fractions were analyzed with a Waters high-pressure
liquid chromatograph equipped with a Waters 2487 dual 
absorbance detector (set at 254 nm), a Waters 2475 multi 
fluorescence detector (excitation, 315 nm; emission, 415 nm), a
Waters 600 controller, and a Waters 717plus autosampler. The
column (4.6  150 mm) was a reversed-phase XBridgeTM C18
(particle size 5 m) purchased from Waters Associates. The
columnwas eluted isocratically with 50mM ammonium acetate
buffer, pH 5.0, plus methanol (89:11, v/v) at room temperature.
Elution profiles were analyzed byWaters EmpowerTM chroma-
tography software. Each experiment included a standard of
N6-ethenoadenine in the appropriate buffer and internal stan-
dards obtained by adding known amounts ofN6-ethenoadenine
to the ethanol-soluble fractions from the control and PAP-
treated RNA. The amount of adenine released from PAP-treated
RNA was calculated from the standards after subtraction of the
fluorescence reading given by control RNA.
Wheat Germ Lysate Translational Assay—Wheat germ
extract was purchased fromPromega. Translation of TEVRNA
was determined in luciferase assay buffer (25 mM Tricine, pH
8.0, 5 mM MgCl2, 0.1 mM ETDA supplemented with 33 mM
DTT, 0.25 mM coenzyme A, and 0.5 mM ATP) for luciferase
activity. A 1.0-g sample of TEV1–143-luc-A50 RNA was trans-
lated in a 200-l reactionmixture containing 50l of complete
wheat germ lysate extract, 50 units of RNase inhibitor, and 10
Mcomplete amino acidmixture (Promega). Luciferase activity
for brome mosaic virus RNA provided by Promega was used as
a control. Equimolar concentrations of PAP, WT VPg, or VPg-
220 were added to the translational mixture as described under
“Results.” Light emissionwasmeasured after the addition of 0.5
mM luciferin as a function of time using the PerkinElmer
Gelience 600 imaging system.
Synthesis of the Fluorescent Anthranoyl-m7GTP—The fluo-
rescent anthranoyl-m7GTP cap analog was synthesized as
described previously (40, 41) with the following modifications.
Them7GTP cap (10mg) was dissolved in 1ml of distilled water
at 37 °C. The pH of the resulting solution was adjusted to 9.6
with 2 NNaOH. To this solution with continuous stirring, crys-
talline isatoic anhydride (5 mg) was added. The pH of the mix-
ture wasmaintained at 9.6 by titrating 2 NNaOHduring the 2-h
reaction. After the reaction was complete, the pH of the reac-
tion mixture was adjusted to 7.0 with 1 N HCl solution. The
reaction mixture containing the products and the unreacted
materials was loaded onto a Sephadex LH-20 (2.4  56-cm)
column equilibrated with autoclaved distilled water. The col-
umn was eluted with the same solvent at a flow rate of about 6
ml/h. Fractions of 1 ml were collected and assayed by TLC on
silica gel. The plateswere developed in systemA (n-propyl alco-
hol/ammonia/water (6:3:1, v/v/v), containing 0.5 g/liter
EDTA). The ant-m7GTP analog had brilliant blue fluorescence
(monitored by a UV lamp), whereas anthranilic acid (a byprod-
uct of this reaction) showed dark violet fluorescence. Peak frac-
tions of the fluorescent analog were pooled, combined, and
lyophilized in vacuo at liquid nitrogen temperature to prevent
degradation. The resulting residue was then dissolved in amin-
imum amount of water (0.5 ml), and an excess of cold ethanol
was added to induce the precipitation of the compound. The
fluorescent cap analog was then dried in vacuo over phosphoric
anhydride at 4 °C, giving an amorphous powder.
Labeling of PAP with NHS-fluorescein—Pokeweed antiviral
protein was labeled with fluorescent N-hydroxysuccinimide
(NHS)-fluorescein reagent using the Pierce NHS-fluorescein
antibody labeling kit (Thermo Scientific) according to theman-
ufacturer’s protocol. NHS-ester labeling reagents react effi-
ciently with primary amines in the side chains of lysine residues
of PAP. PAP storage buffer S was replaced with 50 mM sodium
borate, pH 8.5, buffer, containing 1 mM DTT using Microcon
centrifugal filters (Millipore). The fluorophore/protein ratio
was estimated spectrophotometrically in phosphate-buffered
saline (PBS) by measuring absorbance at 280 and 495 nm (i.e.
Amax of NHS-fluorescein), A280/Amax  0.3. The average
amount of labeling was determined to be 65%. Protein concen-
tration was calculated as follows,
Moles of fluorophore/moles of protein

Amax of the labeled protein
fluor protein
 DF (Eq. 1)
where Amax is the maximum absorbance of the labeled protein,
measured at 495 nm, fluor  70,000 (NHS-fluorescein molar
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extinction coefficient), [Protein] is the molar protein concen-
tration, and DF is the dilution factor. The degree of PAP label-
ing was calculated as follows,
ProteinM 
A280 Amax CF
protein
 DF (Eq. 2)
where A280 is the absorbance of the non-labeled protein, mea-
sured at 280 nm, Amax is the maximum absorbance of the
labeled protein, measured at 495 nm, protein is the molar
extinction coefficient of the non-labeled protein, correction
factor (CF) A280/Amax 0.3, and DF is the dilution factor.
Fluorescence Data Acquisition and Analysis—Steady state
fluorescence was used to monitor protein-protein and protein-
nucleic acid interactions (42). Acquisition of steady state fluo-
rescence in the ultraviolet region allows the use of intrinsic
protein fluorophores to determine equilibrium constants. A
Horiba Jobin Yvon FluoroMax-3 fluorometer with a 150-watt
xenon lamp with photodiode array detectors was used for all
fluorescence measurements. Fluorescence changes (quenching
or enhancement, depending on the titrations) were monitored
using an excitation wavelength of 280 nm and an emission
wavelength of 332 nm (intrinsic protein fluorescence) or using
excitation of 332 nm for the anthranoyl group and 493 nm for
NHS-fluorescein and an emissionwavelength of 420 nm for the
anthranoyl group and 516 nm for NHS-fluorescein (for extrin-
sic fluorophores). All samples were thermoregulated, and the
temperatures weremonitored by a thermocouple in the sample
chamber. All titrations were performed in a titration buffer (20
mM HEPES-KOH, pH 7.5, 100 mM KCl, 1 mM DTT). For each
data point, three samples were prepared. The fluorescence
intensity of a protein (e.g. PAP) was measured in the first sam-
ple. A second sample containing specific amount of titrant pro-
tein (e.g. VPg) was also measured, and the corrected intensities
of the two samples were summed together (Fs). A third sample
containing the same amount of PAP and VPg proteins was
mixed together, and the corrected fluorescence intensity for
this complex was obtained (Fc). The difference in fluorescence
intensity related to the complex was defined as 	F  Fc  Fs.
Similarmeasurements were also performed for other titrations.
The inner filter corrections for the RNA experiments were
applied as described previously (34) using the following equa-
tion (42),
Fc  Fo  antilogAex
 Aem2  (Eq. 3)
where Fc and Fo are the corrected and observed fluorescence
intensities, respectively. Aex and Aem are the absorbance of the
excitation and emission wavelengths, respectively. Corrections
for the dilutions of the titrated samples were taken into consid-
eration as well. The absorbance of the sample was measured
using an Ultrospec 1100 Pro UV-visible absorption spectro-
photometer. The normalized fluorescence difference (	F/
	Fmax) between the protein-protein and protein-RNA com-
plexes and the sum of the individual fluorescence spectra were
used to determine the equilibriumdissociation constant (Kd). A
double reciprocal plot was used for determination of 	Fmax.
The details of the data fitting are described elsewhere (32, 43).
PRISM, version 5, was used to analyze and plot the data. Non-
linear least-squares fitting of plotted normalized data were
used; one-site and two-site binding models were tested.
Evaluation of Thermodynamic Parameters—Thermody-
namic parameters, 	H (van’t Hoff enthalpy), 	S (entropy), and
	G (free energy), were determined using the following
equations,
ln Keq
	H0
RT

	S0
R
(Eq. 4)
	G0  RTlnKeq	H
0 T	S0 (Eq. 5)
where R and T are the universal gas constant and absolute tem-
perature, respectively. Keq is the association equilibrium con-
stant,	H and	Swere determined from the slope and the inter-
cept of a plot of lnKa against 1/T, and	Gwas determined from
Equation 5.
Determination of the Number of Binding Sites—The quench-
ing of the native fluorescence emission maximum upon the
addition of a ligand was monitored for the fluorescence change
relative to untitrated PAP or eIFiso4F. VPg has very low intrin-
sic protein fluorescence. The fractional quench, Q, was deter-
mined at each PAP/VPg or eIFiso4F/VPgmolar ratio (R). For an
observed fluorescence intensity, F, the fractional quench, Q,
was obtained from Equation 6 (44).
Q 
F0  F
m
(Eq. 6)
Herem is the maximal quench.
Fractional quench is linearly related to ligand binding,
Ligand Protein
ProteinT
 Q (Eq. 7)
where [Protein]T represents the total PAP or eIFiso4F protein
concentration. The average number of binding sites (n) was
determined from the x intercept of the Scatchard plotQ versus
Q/(R Q)[Protein]T (44).
RESULTS
PAPDepurinates bothm7GpppG-capped andUncapped S/R,
TEV, and LuciferasemRNA—Because PAP can bind to cap ana-
logs, we determined the extent to which the presence of a cap
on the RNA affected depurination. To examine the extent to
which PAP discriminates between capped and uncapped RNA
transcripts, a synthetic S/R oligonucleotide RNA, TEV RNA,
and luciferase mRNA were used as substrates for PAP enzy-
matic activity. PAP recognized a specific and highly conserved
region, the S/R loop within the large rRNA, and cleaves a dis-
tinct adenine residue (A4324) on the RNA (for the rat liver
ribosome) (9). Previous reports showed that PAP was able to
recognize the cap structure on RNA transcripts (19). It was
postulated that PAP binding to the cap structure promotes the
depurination of capped mRNAs (20). Other findings indicated
that PAP is able to inhibit translation of uncapped RNAs with-
out detectable levels in depurination (21). Both findings are not
mutually exclusive but in fact imply that the cap structure itself
is not enough to promote the depurination of RNA or inhibi-
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tion of RNA translation. To determine whether the cap struc-
ture affects depurination of S/R and TEV RNAs and luciferase
messenger RNA, the above RNAs were capped during run-off
transcription reactions with an m7GpppG cap analog. Separa-
tion using HPLC techniques and identification by means of
fluorescence allowed for construction of a linear relationship
between the amount of 1-N6-ethenoadenosine derived from
the depurination of RNAs and the integrated peak area over a
wide range of 1-N6-ethenoadenosine concentrations (from 10
to 200 pmol) (supplemental Fig. 1A). The amount of adenine
released from WT S/R and WT TEV RNA versus m7GpppG-
capped S/R and TEV RNAs with an addition of increasing
amounts of PAP was determined. Under the conditions of
HPLC, loaded fractions gave a single fluorescent peak with a
retention time of 4.5 min (supplemental Fig. 1, B and C). The
amount of adenine released upon depurination of capped ver-
sus uncapped RNAs was of the same order of magnitude. PAP
depurination did not discriminate between either capped or
uncapped S/R oligonucleotide and capped or uncapped TEV
RNAs (Fig. 1). The amount of adenine released from capped
and uncapped S/R RNA was 14.9  0.8 and 13.7  0.7 nM,
respectively. The amount of adenine released from capped and
uncapped TEV RNA was 6.0  0.4 and 4.1  0.1 nM, respec-
tively. Depurination of uncapped cellular luciferase mRNA
yielded 27.5  0.6 nM adenine released compared with 35.6 
1.8 nM for m7GpppG-capped RNA. These results indicate that
the cap itself had little effect on depurination for naturally
uncapped RNA and only a modest effect on luciferase mRNA.
PAPHas Different Kinetics from Ricin A Chain—To examine
the rates at which PAP depurinates WT TEV RNA, standard
quantification of adenine in the discontinuous assay formatwas
performed. Analysis of the fractions on the HPLC indicated
that RNA depurination by PAP was virtually 80% complete
after 3 min (Fig. 2A). To establish catalytic constants of TEV
RNA depurination by PAP, the RNA concentrations were var-
ied. The progress of the reaction was monitored by the appear-
ance of a UV-absorbing product at the saturating conditions.
Calculated depurination rates were plotted against the RNA
concentrations, resulting in a Michaelis-Menten type behavior
(Fig. 2B). The catalytic constant, kcat, was calculated to be 2.5
min1 (0.042 s1). Fluorescence titrations of NHS-labeled PAP
with RNA produced a Km of 13.6 nM. The specificity constant,
kcat/Km, was calculated to be 3.1  106 M1 s1. This is com-
pared with the specificity constant of ricin A chain for 80S rab-
bit ribosomes of 1.4 108 M1 s1 (45).
FIGURE 1. VPg inhibits PAP depurination of S/R oligonucleotide and TEV RNA. Shown are comparisons of WT (uncapped) S/R oligonucleotide RNA (A)
depurination by PAP (black bars) with that of m7GpppG-capped S/R oligonucleotide RNA (gray bars), WT (uncapped) TEV RNA (B) (black bars) with that of
capped TEV RNA (gray bars), and uncapped and capped luciferase mRNA (C) in the presence and absence of VPg. Error bars, S.E.
FIGURE 2. Kinetics of WT TEV RNA depurination by PAP. A, time course of
adenine released during depurination of RNA by PAP as measured by the
fluorescence of 1-N6-ethenoadenine. Aliquots of PAP-RNA depurinationmix-
tures were withdrawn at different times and loaded directly onto the HPLC
column. Excitation and emission wavelengths were 315 and 415 nm, respec-
tively. B, 1-N6-ethenoadenine assay kinetic curve for depurination catalysis of
RNA by PAP. 100 nM PAPwas treatedwith increasing concentrations of rRNA,
and the amount of released adenine was monitored as described under
“Experimental Procedures.”
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PAP Binds to VPg with Higher Affinity than to eIFiso4F and
m7GTP—The equilibrium binding constants for PAP and VPg
interaction over a range of different temperatures were deter-
mined from fluorescence titration studies (Fig. 3). The equilib-
rium constant for PAP-VPg interaction was determined to be
29.5  1.8 nM at 25 °C (Table 1). This compares with VPg-
eIFiso4FKd of 81.3 nM (31) and PAP-m7GTP binding of 43.3 nM
(23).
PAP Binding to VPg Is Enthalpically Driven and Entropically
Favored—To establish the forces that drive PAP-VPg interac-
tions, the thermodynamics of PAP-VPg binding were deter-
mined. Table 1 shows that the affinity of PAP for VPg decreases
with the increase in temperature (Kd 29.5  1.8 nM at 25 °C
versus 12.5  0.6 nM at 5 °C). The values of 	H0 and 	S0 were
obtained from the intercept and the slope, respectively, of a
van’t Hoff plot (Fig. 3, inset) (correlation coefficient of0.98).
The van’t Hoff analyses showed that the VPg binding to PAP is
enthalpy-driven (	H0  29.2  0.9 kJ/mol) and entropy-fa-
vored (	S0  
46.0  3.0 J/mol), leading to a negative 	G0
(43.0 1.8 kJ/mol). The T	S van’t Hoff component contrib-
utes 32% overall to the value of 	G0 at 25 °C.
PAP and VPg Bind in a 1:1 Ratio—To determine the stoichi-
ometry of PAP-VPg binding, direct fluorescence titration stud-
ies of PAP with VPg were performed (Fig. 4). The slope and
intercept of the Scatchard plotQ/[VPg] 106 versus Q (Fig. 4,
inset) gave the binding constant (Kd 29.5 1.8 nM) and bind-
ing capacity (n 0.99 0.01) of PAP forVPg (44).We conclude
that the PAP and VPg interact in a 1:1 stoichiometric ratio.
PAP and eIFiso4F Bind VPg at Different Sites—VPg-71 is a
truncated variant of wild type VPgwhere theN-terminal amino
acids 1–70 are removed so that it lacks the eIF4F and eIFiso4F
binding sites (32). PAP exhibits 2.8 times stronger binding
affinity for VPg (29.5  1.8 nM) than eIFiso4F (81.3 nM) (31).
The equilibrium constant for PAPVPg-71 was found to be
37.4  3.0 nM at 25 °C. Because VPg-71 has the eIF4F/iso4F
binding sites removed yet still binds PAP with high affinity, we
conclude that the PAP binding site on VPg differs from the
eIF4F binding site on VPg.
VPg and Cap Analog Bind PAP in a Mixed Type Competi-
tion—Competitive binding of VPg and cap to PAP was deter-
mined by employing a fluorescent cap analog, ant-m7GTP (40,
41). The competitive substitution reactions were performed at
constant ant-m7GTP concentration (100 nM), monitoring the
fluorescence change of the analog and increasing amounts of
PAP in the absence and presence of VPg. ant-m7GTP was a
suitable candidate to study these competition interactions
because excitation (332 nm) and emission (420 nm) of this
extrinsic fluorophore are far removed from the protein fluores-
cence, and Kd for the PAP-ant-m7GTP interactions was essen-
tially the same as reported previously for m7GTP interaction
with PAP (Kd 43.3 nM) (23). Lineweaver-Burk plots (Fig. 5A)
meet at the left of the y axis intercept, indicative of mixed type
competitive ligand binding between ant-m7GTP and VPg, sug-
FIGURE 3. Binding isotherms for the interactions of PAP with VPg. The
normalized fluorescence values (ex  280 nm and em  332 nm) for the
fraction of the bound ligand are plotted versus VPg concentration at 5 °C (E),
15 °C (), and 25 °C (‚) (at 25 °C () for PAPVPg-220, control). PAP concen-
tration was 100 nM in titration buffer. The excitation and emission wave-
lengths were 280 and 332 nm, respectively. The curves were fit to obtain
dissociation constants (Kd) as described under “Experimental Procedures.”
Inset, van’t Hoff plot for the interactions of PAP with VPg. ƒ, 10 °C;, 20 °C.
TABLE 1
Equilibrium dissociation constants for the interactions of PAP with
VPg/VPg-71
Complex
Equilibrium dissociation constant (Kd)
5 °C 10 °C 15 °C 20 °C 25 °C
nM
PAPVPg 12.5 0.6 17.0 0.7 20.9 1.2 26.7 1.3 29.5 1.8
PAPVPg-71 NDa ND ND ND 37.4 3.0
aND, not determined.
FIGURE 4. VPg binds more tightly to PAP than to eIFiso4F (complex of
eIFiso4EeIFiso4G). Intrinsic PAP (E) or eIFiso4F () fluorescence was moni-
tored upon binding to VPg. VPg has negligible intrinsic fluorescence. Solid
lines, fitted theoretical curves. Inset, Scatchard plots showing onebinding site
for eIFiso4F and PAP with VPg. The slope and intercept of the straight line
obtained on the plot Q/[VPg] 106 versus Q provided the binding constant
(Ka) andbinding capacity (n) of the aboveproteinswithVPg.Q is the fractional
quench of fluorescence in titration. n for the PAPVPg was determined as
0.99 0.01 and, for eIFiso4FVPg, was 1.05 0.01 (T 25 °C, ex 280 nm,
em 332 nm) (31).
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gesting that VPg binds to PAP at a site distinct from the cap
binding site.
VPg-71 and eIFiso4F Bind PAP Competitively—To deter-
mine if binding of VPg and eIFiso4F to PAP was competitive or
noncompetitive, VPg-71 (a truncated variant of VPg that lacks
the eIFiso4F binding site and does not interact with eIFiso4F),
and N-hydroxysuccinamide (NHS)-fluorescein-labeled PAP
were utilized. The Kd for the NHS-fluorescein-labeled PAP-
m7GTP interactions (63.8 7.9 nM at 25 °C; data not shown) is
in agreement with a previously published WT PAP-m7GTP
value (23), showing that labeling did not affect the protein. The
apparent affinity of labeled PAP for VPg-71 was found to
decrease in the presence of 150 nM eIFiso4F (at 25 °C). Fluores-
cence data were also represented as a double-reciprocal plot
(Fig. 5B) where the lines meet on the y axis, indicating a com-
petitive type ligand binding between VPg and eIFiso4F.
VPg Competes with TEV RNA for PAP Binding—Zeenko and
Gallie (33) have previously demonstrated that the uncapped 5
TEV (tobacco etch virus) UTR contains pseudoknot 1 (PK1)
within its structure that is sufficient to confer cap-independent
translation. VPg had previously been shown to enhance TEV
translation (32) by a mechanism where VPg enhances eIF4F
binding to the TEVmRNA. In order to determine if VPg interac-
tion with PAP affected TEV binding, competition experiments
were performed, where PAP binding to TEV in the presence of
increasing amounts of VPg was determined. A double-reciprocal
plot (Fig. 5C) shows that the lines meet on the y axis, indicating a
competitive type ligand binding between VPg and TEV for PAP.
Unlike eIF4F, VPg competes with PAP for TEV binding.
VPg Decreases PAP-mediated Depurination of S/R, TEV, and
Luciferase mRNA—Having determined that PAP binds to VPg
with a high affinity, and VPg stimulates the in vitro translation
of uncapped IRES-containing RNAby increasing eIF4F binding
(32), we investigated the extent to which the binding of VPg to
PAP could affect PAP activity, possibly by targeting PAP to the
IRES of uncapped viral RNA. VPg in the depurination reactions
decreased depurination of both WT (uncapped) and m7GpppG-
capped RNA constructs. The presence of equimolar concentra-
tionsofVPg toPAP in thedepurinationreactionscompletely abol-
ished the enzymatic activity of PAP, regardless of whether the
RNA transcripts were capped or not (supplemental Fig. 1, B and
C). Fig. 1 summarizes these findings.The results fromthese exper-
iments, consistent with the competitive binding experiments,
show that VPg does not target PAP to IRES-containing RNA nor
S/R RNA but rather acts as a potent inhibitor of PAP activity.
VPg Inhibits Activity of PAP in theWheatGermLysate Trans-
lation System—To examine the PAP depurination activity of
uncapped TEV RNA in wheat germ lysate and investigate how
VPg affects this depurination, uncapped TEV RNA construct
containing the TEV-untranslated region (143 nucleotides,
including an IRES) with the luciferase reporter gene was used
(46). Fig. 6 shows that the addition of PAP to the wheat germ
lysate system after 1 min caused depurination of the RNA and
inhibited translation of the luciferase reporter. The presence of
VPg in the system prior to the addition of PAP caused neutral-
FIGURE5.A, ant-m7GTPcapanalogandVPg showmixedcompetitionbinding
for PAP. Shown is a Lineweaver-Burk plot for competition of ant-m7GTP and
VPg with PAP. The fluorescence change of ant-m7GTP cap analog was mea-
sured with increasing concentrations of PAP. VPg concentrations were 0 nM
(E), 15 nM (‚), and 30 nM (). The excitation wavelength was 332 nm, and
emission was 420 nm. The spectrum was measured in buffer containing 100
nM ant-m7GTP and VPg as indicated. Data points were fitted using least
square analysis. B, eIFiso4F and VPg-71 bind competitively to NHS-fluoresce-
in-labeled PAP. Lineweaver-Burk plots of competitive binding are presented.
The fluorescence change of NHS-fluorescein-labeled PAP (200 nM) was mon-
itored (ex  493 nm, em  516 nm) with increasing concentrations of
VPg-71 in thepresenceandabsenceof eIFiso4F (0 (E), 50 (), 100 (‚), and150
nM ()). Data points were fitted using least square analysis. C, VPg and TEV
RNA bind competitively to NHS-fluorescein-labeled PAP. Lineweaver-Burk
plots show competitive binding. The fluorescence change of NHS-fluoresce-
in-labeled PAPwasmonitored (ex 493 nm, em 516 nm)with increasing
concentrations of TEV RNA in the presence and absence of VPg (0 (E), 30 (ƒ),
50 (), and 100 nM (‚)). Data points were fitted using least square analysis.
FIGURE 6. Translation of luciferase reporter TEV RNA constructs inwheat
germextracts. Luciferase relative light units (RLU) weremeasured for TEV(1–
143)-luc-A50 RNA (E), TEV(1–143)-luc-A50 RNA
WTVPg (), TEV(1–143)-luc-
A50 RNA
PAPafter 1min (ƒ), TEV(1–143)-luc-A50 RNA
WTVPg
PAPafter
1 min (Œ), and TEV(1–143)-luc-A50 RNA 
 VPg-220 
 PAP after 1 min () in
wheat germ translational extract as a function of time. The proteins were
added in the stoichiometric concentrations (10 nM) in the presence of 1.0 g
of TEV(1–143)-luc-A50 RNA, and light emission was measured after the addi-
tion of 0.5 mM luciferase substrate.
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ization of the enzymatic activity of PAP and rapid translation of
the luciferase reporter by thewheat germ translationalmachin-
ery. This indicates that VPg serves as an inhibitor of PAP in
wheat germ lysate. VPg-220, a truncated mutant of VPg that
lacks the C-terminal portion of the protein, was used as a neg-
ative control for the PAP-VPg interactions. The VPg-220 vari-
ant did interact with PAP with10-fold lower affinity (Fig. 3);
however, it did not affect PAPenzymatic activity, as determined
by the fluorescence assay. The presence of VPg-220 in the
translational system did not show any increase in translation of
the luciferase reporter compared with WT VPg.
DISCUSSION
PAP is a highly toxic protein produced by the pokeweed cells
and exported outside the cells once synthesized (47, 48). Stor-
age of PAP within extracellular spaces ensures close proximity
of PAP to ribosomes. When a pathogen infects the cell, PAP
also gains entrance and disrupts cellular protein synthesis, thus
killing the pathogen-infected cell and thereby preventing
pathogen replication (49).
Khan et al. (32) have characterized interactions between
VPg, plant eIFiso4E/iso4F, eIF4F, and TEVRNA and concluded
that VPg increases the binding affinity of eIF4F for TEV RNA.
The requirement for eIF4G in cap-independent translation (34)
has been demonstrated, and a mechanism was proposed where
VPg substitutes for the cap analog and enhances formation of
an eIF4F complex with viral IRES (31, 32). We therefore
hypothesized that VPgmay interact with PAP and possibly tar-
get it to uncapped RNA.
The rationale of our investigation was that PAP, being a cap-
binding protein, will bind to VPg that functions as a cap analog,
and these interactions would affect depurination of uncapped
viral RNA or capped cellular RNA. VPg stimulates the in vitro
translation of uncapped IRES-containing RNA and inhibits
capped RNA translation. Our research indicated that PAP has a
high affinity for VPg and that this affinity is almost twice that of
them7GTP analog (23). Greater affinity of PAP forVPg than for
the cap structurewould produce an advantage for the cell if VPg
were to localize PAP to viral RNA for depurination. However,
VPg inhibits PAP activity, providing ameans to avoid one of the
potential host cell defense mechanisms.
The thermodynamic parameters of PAP-VPg binding are
similar in magnitude to those of eIFiso4E- or eIFiso4F-VPg
binding. Both interactions are enthalpically driven and entropi-
cally favored. The T	S van’t Hoff component contributes
nearly one-third to the overall value of 	G0 (at 25 °C), suggest-
ing lesser dependence on electrostatic contributions and a
greater conformational contribution in the PAP-VPg binding
with hydrophobic residues less solvent-exposed in the com-
bined structure. The fact that PAP-VPg interactions are enthal-
pically driven and entropically favored at biological tempera-
tures supports previous observations by Baldwin et al. (23) that,
because PAP is a plant defense protein, it should be able to
perform under unpredictable temperature conditions, given its
accepted function as a ribosome depurinating agent (23).
Different equilibrium dissociation constant (Kd) values for
PAP-VPg compared with eIFiso4E- or eIFiso4F-VPg binding
suggest differences between the active site of PAP and the cap-
binding sites of eIFs. Le´onard et al. (26, 30) have established
previously the interactions between VPg and various isoforms
of eIF4E, and Khan et al. (31) have quantified eIF4E/iso4E-VPg
interactions as competitive with the m7GTP cap analog (26).
Moreover, the binding domain on VPgwasmapped to a stretch
of 35 amino acids, and substitution of aspartic acid residue
found within this region completely abolished interactions of
VPg with eIF4E/iso4E (26). Plants infected with a TuMV
infectious cDNA (p35Tunos) showed viral symptoms with
p35Tunos, whereas plants infected with p35TuD77N, amutant
that contained the aspartic acid substitution in the VPg domain
that abolished the interaction with eIF4E/iso4E, remained
symptomless, suggesting that VPg-eIF4E/iso4E interaction is a
critical element for virus production (26). VPg-71 lacks the
eIF4F/iso4F binding sites (32); however, PAP was able to bind
VPg-71, indicating that the PAP binding site remains present in
VPg-71 and does not include, at least partially, the amino ter-
minus of the protein.
Having determined the binary interactions between PAP,
VPg, and eIFiso4F, we have examined the ternary interactions.
A summary of directly measured binary and ternary complexes
is schematically presented in Fig. 7. The equilibrium associa-
tion constants K1, K2, and K5 were directly measured by fluo-
rescence titration experiments; K3 was fromKhan et al. (31). In
Fig. 7, K4 and K6 were chosen as the thermodynamically
dependent equilibrium constants and were calculated from the
relationships shown in Equations 8 and 9.
K4 
K2K5
K1
(Eq. 8)
K6 
K2K5
K3
(Eq. 9)
A comparison of the cross-terms in Fig. 7 shows that the
binding of eIFiso4F to PAP diminishes the binding of VPg
(comparingK1 andK5); similarly, the binding of eIFiso4F toVPg
diminishes the binding of PAP (comparing K3 and K5).
FIGURE 7. Schematic representation of the interactions between PAP,
VPg, and eIFiso4F. K1, K2, K3, and K5 were determined experimentally; K4 and
K6 were calculated as described under “Discussion.” Binding and coupling
free energies (kJ/mol) for PAP, VPg, and eIFiso4Fwere calculated according to
the Kd values. All equilibrium constants cited are 10
6
M
1.
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In order to quantitate these interactions, coupling energies
were calculated according to the method of Weber (50) and as
previously described in detail (51, 52). The coupling energies
reflect the overestimation and underestimation of the free
energy of binding for the formation of ternary eIFiso4F
VPgPAP complex, 	G0(eIFiso4FVPgPAP), calculated from the
addition of the component binary energies for the interac-
tion of eIFiso4F with PAP, 	G0(eIFiso4FPAP), or with VPg,
	G0(eIFiso4FVPg), and PAP with VPg, 	G0(PAPVPg). These cou-
pling energies therefore represent different binding perspec-
tives and are defined by Equations 10–12.
	GeIFiso4F, VPgPAP)
0 	G(eIFiso4FVPgPAP)
0
 	GeIFiso4FVPg)
0 	GeIFiso4FPAP)
0
(Eq. 10)
	GPAP, eIFiso4FVPg)
0 	GeIFiso4F, VPgPAP)
0
 	GeIFiso4FVPg)
0 	GPAPVPg)
0
(Eq. 11)
	GVPg, eIFiso4FPAP)
0 	GeIFiso4F, VPgPAP)
0
 	GeIFiso4FPAP)
0 	GPAPVPg)
0
(Eq. 12)
The values for 	G0(eIFiso4FPAP), 	G0(VPgPAP), and
	G0(eIFiso4FVPg) were determined from K1, K2, and K3 in Fig. 7,
respectively. 	G0(eIFiso4FVPgPAP) values were determined from
the addition of the	G0 values calculated fromK2 andK5. These
interaction energies indicate how the binding of one compo-
nent to its site affects the binding of a second component to its
site; thus, each component (PAP, VPg, and eIFiso4F) is created
as if it possesses two binding sites. For instance, 	Go(PAP,
eIFiso4FVPg) shows how the binding of eIFiso4F to one site on
PAP affects the affinity of the VPg for its binding site on PAP.
The coupling energies may be positive, negative, or zero,
depending on whether the interactions are anticooperative,
cooperative, or noncooperative due to the binding of the sec-
ond component, respectively (52). The coupling energies calcu-
lated in this manner are presented in Fig. 7.
The binding of either PAP or VPg to eIFiso4F enhances
the subsequent binding of the second factor to eIFiso4F,
	G0(eIFiso4F, VPgPAP) is1.5 kJ/mol, which is indicative of coop-
erative heterotropic interaction between these proteins. On the
other hand, the binding of either VPg or eIFiso4F to PAP is
anticooperative (	G0(PAP, eIFiso4FVPg)
1.1 kJ/mol) and sup-
ports competitive type binding between VPg and eIFiso4F, as
previously determined. This suggests that the eIFiso4F-VPg
interaction may prevent VPg from interacting with structural
features of the PAP. The binding of PAP or eIFiso4F to VPg
(	G0(VPg, eIFiso4FPAP)
0.1 kJ/mol) is relatively indifferent to
the subsequent binding of the second component to VPg. From
these data, a mechanism can be proposed for the sequence of
events leading to the formation of PAPVPgeIFiso4F complex
with subsequent inhibition of depurination of TEV-derived
RNA. Two models are possible, where PAP first forms a binary
complex with eIFiso4F initiation factor, with the subsequent
binding to VPg, or PAP binds to a preformed eIFiso4FVPg
binary complex. Both models lead to a ternary PAPVPgeIFiso4F
complex formation, which brings PAP to close proximity with
viralRNA.However, theabovecooperative interactionshinder the
enzymatic site of PAP from the depurination of RNA, thus pro-
moting inhibition of the plant’s defense mechanism.
Because cap-binding proteins bind to VPg similarly to cap
analogs, andVPg stimulates the in vitro translation of uncapped
IRES-containing RNA and inhibits capped RNA translation in
wheat germ extracts (32), we have analyzed the extent to which
VPg can selectively target PAP to uncapped IRES-containing
viral RNA, in contrast to its ability to target eIF4F to TEV RNA
(32). Instead, VPg inhibits depurination of both capped and
uncapped S/R oligonucleotides and IRES-containingTEV tran-
scripts. Inhibition of enzymatic activity of PAP is supported in
the wheat germ lysate translational system (Fig. 6), indicating
that VPg can inhibit PAP even in the presence of other cellular
components. This inhibition of the depurinating activity of
PAP is concentration-dependent; equimolar concentrations of
VPg completely abolish the enzymatic activity of PAP. VPg has
been implicated in overcoming viral resistance in plants (25).
Extreme toxicity of PAP to plant cells does not allow expression
of the protein in vivo and subsequent studies of PAP interaction
with VPg. However, in support of the in vivo relevance of our
findings is the fact that pokeweed mosaic virus, a VPg-linked
viral species, is the only virus to our knowledge reported to
infect P. americana (53).
Our findings further support thenotionthatVPgmayplayarole
in overcoming viral resistance by suppressing the defensemecha-
nism of the plant. Furthermore, depurination inhibition by VPg
also suggests the possible use of this protein against cytotoxic
activity of RIPs and inhibition of their biological potency.
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SUPPLIMENTAL FIGURE 1. HPLC chromatogram of S/R oligo and TEV RNA depurination by PAP 
in the absence and presence of increasing amounts of VPg. (A) 1-N6-Ethenoadenine standard curve. All 
points were fitted in triplicate values resulting in r2 = 0.98 and y = 408x – 5170 equation of the line. The 
peaks were eluted isocratically with 50 mM ammonium acetate buffer (pH 5.0)/methanol (89:11, v/v) at 
room temperature. (B) m7GTP-capped and uncapped S/R oligo RNA; (C) m7GTP-capped and uncapped 
TEV RNA. The amount of 1-N6-ethenoadenine was monitored at the excitation wavelength of 315 nm 
and emission wavelength of 415 nm (1, 100 nM RNA; 2, 100 nM RNA + 50 nM PAP; 3, 100 nM RNA + 
100 nM PAP; 4, 100 nM RNA + 100 nM PAP + 25 nM VPg; 5, 100 nM RNA + 100 nM PAP + 50 nM 
VPg; 6, 100 nM RNA + 100 nM PAP + 100 nM VPg). 
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